: /1 Other income comprises mainly of interest income and services revenue Cost of Goods Sold Cost of goods sold for the nine months period ended 3 0 September 2 0 1 8 and 2 0 1 9 stood at THB 319.38
able to conserve cash to ensure that the Group is in a solid position going forward. Although the financial impacts from all the cost savings measures could not compensate for the loss of revenue in the
% Adjusted EBITDA Margin (%) 1.0% 9.3% -8.3% 4.4% -3.4% 4.3% 8.6% -4.3% Net Profit -97 185 -152% -36 169% -113 317 -136% Item from raw materials derogation - - n.a. 14(2) -100% 16(2) -2,004 -101% Tax income
. Inventory gains/losses in a period result from the movement in prices of raw materials and products from the end of the previous reported period to the end of the current reported period. The cost of sales is
government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is
[1Q20 VS. 4Q19] [1Q20 VS. 1Q19] FX: THB/USD 31.1053 30.0127 31.3204 Sales Revenue, THB 3,259.7 2,902.4 +12.3% 3,113.9 +4.7% [ Sales Revenue, USD $104.8 $96.7 +8.4% $99.4 +5.4% ] Cost of Sales 2,477.7
and THB 317.09 million, respectively, equivalent to a 75.79 % increase. Cost of goods sold to sales revenue ratio increased from 32.36 % to 45.16% because of the raw material and packaging increased 115
2019 Change % Change Revenue from sales & service 411.58 719.81 -308.23 -42.8% Other income 5.01 5.57 -0.56 -10.1% Total revenue 416.59 725.38 -308.79 -42.6% Cost of goods sold & service 383.13 638.35
, compared with 63.58% for the same period last year. The increase in gross profit margin was mostly because the Group had better cost management especially the reduction in the price of raw material which is
2,142.0 Mn and THB 2,209.0 Mn respectively, an increase of THB 67.0 Mn or 3.1%. This was mainly due to (1) the opening of new branches, (2) increased sales of delivery, (3) increased sales of raw material